相关实验视频

Updated: Jan 13, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

作为实验性肺炎球菌脑膜炎的辅助治疗,西洛利木斯抑制mTORC1

Rutger Koning¹, Dixie Bakker¹, Marian A van Roon¹

¹Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, 1105 AZ Amsterdam, the Netherlands.

Brain communications

|January 12, 2026

概括

在肺炎球菌性脑膜炎小鼠模型中,西洛没有改善生存率. 这种mTORC1抑制剂增加了炎症和疾病严重程度,表明它不是一种有效的治疗方法.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

肺炎球菌脑膜炎是一种严重的感染,死亡率和发病率很高.
斯洛利木斯是一种哺乳动物目标拉巴胺复合物1 (mTORC1) 的抑制剂,可调节炎症,并已被研究其潜在的治疗益处.
mTORC1信号传递在调节炎症反应和脑膜炎相关的细胞过程中发挥作用.

研究的目的:

在小鼠模型中研究mTORC1抑制剂西罗的疗效,作为试验性肺炎球菌脑膜炎的治疗方法.
在肺炎球菌脑膜炎的背景下,评估西洛对临床严重程度,生存率,细菌负载和炎症标志物的影响.

主要方法:

一项前性,调查者盲目的随机试验,涉及96只感染*Streptococcus pneumoniae*血清型2的小鼠.
小鼠接受了抗生素治疗,同时服用西洛利或对照剂.
在72小时内,每4小时评估一次临床严重程度,并分析细菌负载和炎症标志物 (间白蛋白) 的特定时间点 (感染后6小时和24小时).

主要成果:

在肺炎球菌脑膜炎的小鼠中,sirolimus治疗没有显著改善生存率.
赛洛利斯治疗导致临床严重性得分增加和炎症加剧,脑和血中介质素-6和介质素-12水平升高.
在西罗治疗组和对照组之间,细菌负载仍然相似,这表明观察到的效应是由于免疫调节而不是直接的抗微生物活性.

结论:

赛洛斯治疗不太可能是肺炎球菌脑膜炎的有效治疗策略.
在肺炎球菌脑膜炎期间,mTORC1信号传递对于调节炎症至关重要,但其在西洛林斯的抑制会加剧疾病.
需要进一步的研究,以了解mTORC1在脑膜炎中的复杂作用,并确定潜在的治疗点.

关键词:

肺炎链球菌的肺炎链球菌.这是细菌性脑膜炎.实验性脑膜炎的研究在 mTORC1 的情况下,mTORC1 是这是西洛利斯 ( sirolimus).

更多相关视频

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...